Evidence map›Paper›PMID 31792757›Full record

ArticleInflammation2020

Immunostimulatory Activities of Coliphages on In Vitro Activated Mammalian Macrophages.

Gizem Yıldızlı, Gokhan Coral, Furkan Ayaz

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Bacteriophage-based decontamination to control environmental colonization byFrontiers in cellular and infection microbiology · 2022
    Article
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gizem YıldızlıDepartment of Biotechnology, Faculty of Arts and Science, Mersin University, 33343, Mersin, Turkey.
Gokhan CoralDepartment of Biotechnology, Faculty of Arts and Science, Mersin University, 33343, Mersin, Turkey. coral@mersin.edu.tr.
Furkan AyazDepartment of Biotechnology, Faculty of Arts and Science, Mersin University, 33343, Mersin, Turkey. furkanayaz@mersin.edu.tr.ORCID http://orcid.org/0000-0003-0271-0594
Mersin Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages present alternatives to antibiotics. In the age of superbugs and antibiotic resistance, the field of medicine is trying to create new antibiotics or derivatives of the old ones to eliminate bacterial infections. Bacteriophages are specific to a certain type of bacterial species and effectively kill the bacteria of target. In order to effectively use the bacteriophages as medicine, their possible side effects should be properly analyzed and one of those includes their activities on the immune system cells. In this study, we isolated two new Escherichia coli bacteriophages and tested their effect on the activation state of the mammalian macrophages. The bacteriophages were host specific and had substantial adsorption rates on E. coli. Moreover, they were able to effectively stimulate the macrophages in the absence of a bacterial stimulant, lipopolysaccharides. This implies that these bacteriophages can be used against E. coli infections in which proper immune system activation is missing. This study is the first one to our knowledge specifically showing the immunostimulatory effect of newly isolated E. coli bacteriophages on the macrophages. It is important to determine the effect of bacteriophages on the immune system cells before their use as antibiotics.

Indexed as

AnimalsBacteriophagesCell SurvivalColiphagesEscherichia coliImmunizationInflammation MediatorsMacrophagesMiceRAW 264.7 CellsInflammation MediatorsbacteriophagescoliphagesE. coliimmune systemmacrophages

Identifiers

PMID31792757
OpenAlexW2990309734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.